Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients

<table>(a) Kaplan-Meier depiction of locoregional control for all patients, (b) univariate analysis of clinical characteristics potentially associated with locoregional control.</table>

International Journal of Otolaryngology

fig2

Figure 2

Figure 2: Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients 

Figure 2 | Hyperfractionated Radiotherapy with Concurrent Cisplatin/5-Fluorouracil for Locoregional Advanced Head and Neck Cancer: Analysis of 105 Consecutive Patients 